Surims Ltd Logo
 
 
 
 
 
 
BD Banner Ad
 

Search Pharmaceutical Licensing and Partnerships

Our directory contains a comprehensive list of pharmaceutical licensing and partnership opportunities. Use the search options to find the perfect partner for your business, whether generic medicines or patent protected products to License-in or License-out.

 

Save This Search | View as Grid | Order by Recently Added | Order by Company Name

  • Total Results: 912
  • Total Pages: 46
 
 
 
Zosano Pharma Logo
 
USA
 
34790 Ardentech Court, Fremont, 94555
 
Zosano Pharma is actively seeking partnerships that utilize our proprietary transdermal microneedle patch technology.
Zosano’s delivery technology has the capability to provide a room temperature stable, transdermal product to support a wide-spread deployment of a therapeutic solution.
 
 
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Minapharm Logo
 
Egypt
 
El-Bardissi St.,, 2T Takseem Asmaa Fahmy St.,, Heliopolis, Cairo,
 
Strategic multi-alliances with world leaders at the leading edge of fast developing technologies within their specifities has positioned MINAPHARM at the forefront of the latest pharmaceutical technologies, marketing and managment techniques. Furthermore, this has also enabled MINAPHARM to establish specialized lines embracing relevant innovative products and services in the fields of Cardiology, Gastroenterology, Ophthalmology, Dermatology and Biotechnology.
 
 
  • Licencing In
  • Distributor
 
Basic Profile
 
Incyte Logo
 
Incyte
 
USA
 
1801 Augustine Cut-Off, Wilmington, Delaware, 19803
 
We enjoy working with like-minded partners who want to join forces to improve the lives of patients. Incyte is a company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can improve patients’ lives. We recognize that we do not have a monopoly on good ideas and innovative approaches to therapy. We are committed to alliances, partnerships and collaborations and will opportunistically evaluate assets that have the potential to expand our pipeline,…
 
 
  • Licencing In
  • Research and Development
 
Basic Profile
 
Seagen Logo
 
Seagen
 
USA
 
21717 30th Drive S.E., Building 3, Bothell, WA, 98021
 
Our partnerships focus on: 

Innovative in-licensing opportunities at all development stages to diversify and grow our emerging global portfolio 
Clinical and research collaborations that broaden the potential of our internal programs
Novel platform technologies that synergize with or expand our antibody–drug conjugate (ADC) capabilities in new and unique ways
 
 
  • Licencing In
 
Basic Profile
 
Progenity Logo
 
USA
 
4330 La Jolla Village Dr, UNIT 200, San Diego, CA, 92122
 
Current therapeutics offer poor efficacy in many IBD cases. GI tract inflammation and lesions contribute to this poor efficacy by accelerating drug loss into the GI tract. Achieving higher drug concentrations in the diseased tissues may lead to improved drug response and remission rates in patients suffering from IBD. Progenity’s targeted delivery platform offers the ability to accurately localize and deliver drugs at the site of disease in the GI tract. This will enable the necessary therapeutic tissue dose, improving efficacy while limiting systemic exposure…
 
 
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Ab Studio Inc Logo
 
USA
 
3541 Investment Blvd, Suite 2-3, Hayward, California, 94545,
 
Three patented novel technology platforms: Partnership CAAD for regular therapeutic antibody design: ServiceApply Ab Studio’s unique methodology to screen hybridoma clones secreting cancer-specifc internalization antibodies or phages displaying internalization antibodies Apply “knob into hole” and common light chain technologies for bispecific antibody development Use Ab Studio’s unique methodology to screen common light chains Apply computer-aided design to engineer the two arms of a bi-specifc antibody for optimal purification efficacy
 
 
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Enteris BioPharma Logo
 
USA
 
83 Fulton Street, Boonton, NJ, 07005
 
Enteris BioPharma leverages its Peptelligence® platform to build long-term relationships with companies that recognize the business value and patient advantages of developing orally delivered peptide and small molecule therapeutics. Peptides and small molecules with poor…
 
 
  • Licencing Out
  • Research and Development
 
Basic Profile
 
ADVANZ Pharma Logo
 
United Kingdom
 
11-15 Seaton Place, St Helier, Jersey, JE4 0QH
 
Our virtual operating model combined with regulatory, quality and supply-chain functions, a commercial platform in almost 100 countries and a solid track record in selling and marketing products in these countries means we can acquire and integrate new products and companies quickly and efficiently.
 
 
  • Licencing In
 
Basic Profile
 
Caribou Biosciences, Inc Logo
 
USA
 
2929 7th Street, Suite 105,, Berkeley,, CA, 94710
 
CRISPR genome editing uses easily designed, modular, biological tools to make DNA changes in living cells. There are two basic components of CRISPR systems: the nuclease protein(s) that cut DNA and the RNA molecule(s) that guide the nuclease to generate a site-specific, double-stranded break, leading to editing at the targeted genomic site. CRISPR systems occasionally edit unintended genomic sites, known as off-target editing, which may lead to harmful effects on cellular function. In response to this challenge, Caribou has developed chRDNAs (pronounced “Chardonnays”),…
 
 
  • Research and Development
 
Basic Profile
 
Kytopen Logo
 
Kytopen
 
USA
 
501 Massachusetts Ave, Cambridge, Massachusetts,
 
The Flowfect™ technology combines continuous fluid flow with electric fields for high efficiency delivery of payloads such as mRNA, DNA, and CRISPR Cas9 RNP to primary cells. By carefully synchronizing the…
 
 
  • Research and Development
 
Basic Profile
 
Sutro Biopharma Logo
 
USA
 
310 UTAH AVE SUITE 150 SOUTH, San Francisco, CA 94080
 
Sutro initiated a collaboration with Merck & Co. in July, 2018, known as MSD outside the United States and Canada, to discover and develop novel immune-modulating therapies for cancer and autoimmune disorders. The research and development activities leverage Sutro’s proprietary cell-free protein synthesis and site-specific conjugation platforms, which facilitate precision design and rapid empirical optimization of protein conjugates, to discover and develop best-in-class immune-modulating cytokine derivatives for both oncology and autoimmune indications.
 
 
  • Licencing In
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Luye Pharma AG Logo
 
Germany
 
Am Windfeld 35, Miesbach, 83714
 
As a trusted partner to many high-profile pharmaceutical companies, we offer an all-inclusive licensing package for our transdermal patches. Licenses are granted to sell these products in regions where the relevant active substances have already been approved. We do not license products that are still in our development pipeline. Our partners are responsible for all marketing activities in the target markets, while we manufacture the patches and handle all patent and regulatory issues as the…
 
 
  • Licencing Out
  • Research and Development
 
Basic Profile
 
ANANDA Devices Logo
 
Canada
 
500 Boulevard Cartier Ouest #129, Laval, QC,
 
We provide in-house customized biological research services using our innovative assay models. ANANDA’s technology brings in vitro assays into the 21st century. We offer unique proprietary nano-scale solutions that accelerate research programs by increasing the standardization, precision, reproducibility, and physiological relevance of cellular assays. We have over 50 proprietary designs for various in vitro applications ranging from neurons to skins to hair, with many more in development.
 
 
  • Research and Development
 
Basic Profile
 
Emergex Vaccines Logo
 
United Kingdom
 
4/5 Dunmore Court, Wootton Road, Abingdon, OX13 6BH
 
We have partnered with the IMCB of Singapore to develop a vaccine for the emerging threat of Hand, Foot and Mouth (HFM) disease.
 
 
  • Research and Development
 
Basic Profile
 
Genor BioPharma Logo
 
China
 
1690 Zhangheng Road, Building 3, Pudong New District,, Shanghai,
 
  • Licencing In
 
Basic Profile
 
Innovent Biologics Logo
 
China
 
168 Dongping Street,, Suzhou Industrial Park, Suzhou, Jiangsu, 215123,
 
Built with an innovation mindset, Innovent has established a product pipeline targeting therapeutic areas including oncology, ophthalmology, autoimmune diseases, and cardiovascular diseases. In the nine years since its founding, Innovent Biologics has entered into strategic collaborations with multiple prestigious corporations and research institutes in China and around the world. The Multiple strategic cooperation agreements entered into by Innovent and Eli Lilly, with over US$2.5Bn of economic interest involved, have set records for deals between Chinese players and MNCs.
 
 
  • Licencing In
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Oakwood Labs Logo
 
USA
 
7670 First Place, Suite A, Oakwood Village, OH, 44146
 
Developing a product from concept to commercialization requires successful partnership. With over 20 years of experience partnering with global pharmaceutical firms large and small, we understand what it takes to be an effective partner. We pride ourselves on our ability to achieve milestones within set deadlines, provide transparent communication, be adaptable to change, and offer our expertise throughout the process.
Patented microsphere technology allowing tailored release profile from weeks to one year
 
 
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Acuitas Therapeutics Logo
 
Canada
 
6190 Agronomy Road, Suite 405, Vancouver, BC, V6T 1Z3
 
Acuitas partners locally and globally with companies, academic…
 
 
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Intravacc Logo
 
Netherlands
 
Utrecht Science Park Bilthoven, Antonie Van Leeuwenhoeklaan 9, Bilthoven, 3721 MA
 
Partnering  Intravacc collaborates with universities, government institutions, biotech and pharma companies world-wide. We aims to (co-)develop…
 
 
  • Licencing In
  • Licencing Out
  • Research and Development
 
Basic Profile
 
Clover Biopharmaceuticals Logo
 
China
 
3102-6 Hong Kong New World Tower (K11), 300 Middle Huaihai Road,, Shanghai, 200020
 
The COVID-19 pandemic presents unprecedented challenges to communities around the world. Members of the scientific and public health communities need to collaborate with each other now more than ever to tackle this disease. In response to the global COVID-19 pandemic, Clover entered into partnerships with the Coalition for Epidemic Preparedness Innovations (CEPI), GSK, and Dynavax for the advancement of its COVID-19 vaccine program. We aim to work with our partners to deliver safe and effective vaccines to all countries and regions affected by the pandemic.
 
 
  • Licencing In
  • Licencing Out
  • Research and Development
 
Basic Profile
 
 
  • Total Results: 912
  • Total Pages: 46
 
 
USP Banner
 
 

Partnerships and Licensing in the Pharmaceutical Industry

Partnerships and licensing activities between innovators and pharmaceutical service providers are now mainstream activities within our hi-tech industry. This can decrease product development times, bringing products to market quicker while reducing cost.

Our online directory provides customised search capabilities to quickly identify activities in the area of pharma technology, relationship type, pharmaceutical form, therapeutic application or drug delivery innovations.

Our partnership data is integrated with our software applications allowing you to quickly identify a suitable partner and qualify and initiate either a development project or supply agreement.

Take the Next Step

We update the partnerships and licensing companies daily. If you would like to add your company to the directory, you can do so for free ...
Register for an account to add your licensing and partnership details »

Should you have any questions or require further information please contact us ...
Contact the support team »

Check if your company is listed and claim your online profile ...
Search for your company listing »

 

 
PCI
 
Marouho vertical
 
Register small banner
 
small vertical ad
 
banner vertical
 
 
 
 
 
 
 

About Us

Surims Ltd is a consultancy established in 2003 supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at https://www.surims.com.

 
 
 

Get in Touch

The Pharmaceutical Services Directory
info@pharmaservicesdirectory.com

 
 

© 2021 Surims Ltd | All Rights Reserved.